Hopkins Lupus Cohort - 1999 update

被引：99

作者：

Petri, M ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Hopkins Lupus Cohort, Baltimore, MD 21205 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2000年 / 26卷 / 02期

关键词：

D O I：

10.1016/S0889-857X(05)70135-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The Hopkins Lupus Cohort is a decade-long prospective study, now numbering 800 patients with systemic lupus erythematosus. In this article, predictors of disease activity, disease damage (including accelerated atherosclerosis and antiphospholipid antibody syndrome) and health status are reviewed.

引用

页码：199 / +

页数：16

共 39 条

[1]

Akkasilpa Somchai, 1997, Arthritis and Rheumatism, V40, pS209

[2]

AUSTIN HA, 1995, NEPHROL DIAL TRANSPL, V10, P1620

[3] Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans [J].

Dooley, MA ;

Hogan, S ;

Jennette, C ;

Falk, R .

KIDNEY INTERNATIONAL, 1997, 51 (04) :1188-1195

[4] Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus - Why some tests fail [J].

Esdaile, JM ;

Abrahamowicz, M ;

Joseph, L ;

MacKenzie, T ;

Li, Y ;

Danoff, D .

ARTHRITIS AND RHEUMATISM, 1996, 39 (03) :370-378

[5] SYSTEMIC LUPUS-ERYTHEMATOSUS IN COMMUNITY - INCIDENCE, PREVALENCE, OUTCOME, AND FIRST SYMPTOMS - HIGH PREVALENCE IN BLACK WOMEN [J].

FESSEL, WJ .

ARCHIVES OF INTERNAL MEDICINE, 1974, 134 (06) :1027-1035

[6] The development and initial validation of the systemic lupus international collaborating clinics American College of Rheumatology Damage Index for Systemic Lupus Erythematosus [J].

Gladman, D ;

Ginzler, E ;

Goldsmith, C ;

Fortin, P ;

Liang, M ;

Urowitz, M ;

Bacon, P ;

Bombardieri, S ;

Hanly, J ;

Hay, E ;

Isenberg, D ;

Jones, J ;

Kalunian, K ;

Maddison, P ;

Nived, O ;

Petri, M ;

Richter, M ;

SanchezGuerrero, J ;

Snaith, M ;

Sturfelt, G ;

Symmons, D ;

Zoma, A .

ARTHRITIS AND RHEUMATISM, 1996, 39 (03) :363-369

[7]

GORGOS L, 1993, ARTHRITIS RHEUM, V36, pA17

[8] Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity [J].

Manzi, S ;

Rairie, JE ;

Carpenter, AB ;

Kelly, RH ;

Jagarlapudi, SP ;

Sereika, SM ;

Medsger, TA ;

RamseyGoldman, R .

ARTHRITIS AND RHEUMATISM, 1996, 39 (07) :1178-1188

[9]

Petri M, 1999, J RHEUMATOL, V26, P502

[10] CORONARY-ARTERY DISEASE RISK-FACTORS IN THE JOHNS-HOPKINS LUPUS-COHORT - PREVALENCE, RECOGNITION BY PATIENTS, AND PREVENTIVE PRACTICES [J].

PETRI, M ;

SPENCE, D ;

BONE, LR ;

HOCHBERG, MC .

MEDICINE, 1992, 71 (05) :291-302

← 1 2 3 4 →